About Multilab
Multilab is a Healthcare company based in Porto Alegre (Brazil) founded in 1988, and was acquired by Takeda in May 2012. Information on gift card cashing options and methods is provided. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. Multilab offers products and services including ResfeGripe, Buprovil, Multipiral, and Nexoprax. Its focus areas include Pharmaceuticals and Generic Drugs. Its legal entity is Multilab Indústria e Comércio de Produtos Farmacêuticos Ltda.
Company details
Multilab, a Brazilian company, is involved in the research, development, production, and distribution of pharmaceutical products across various therapeutic areas. It operates within the healthcare sector, offering a wide portfolio of medications, including prescription and over-the-counter drugs. As part of Grupo NC, one of the largest pharmaceutical groups in Latin America, Multilab focuses on providing accessible medicinal solutions through a presence in over 87,000 points of sale. Its offerings address diverse health needs with a commitment to quality and trust.
- Headquarters Porto Alegre, Brazil
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website multilab.com.br
- Social X Facebook Instagram
- Acquired by Takeda (May 2012)
- Legal Name Multilab Indústria E Comércio De Produtos Farmacêuticos Ltda
- Investors
- Acquired byTakeda
(May 2012)
Products & Services of Multilab
Multilab offers a comprehensive portfolio of products and services, including ResfeGripe, Buprovil, Multipiral, and Nexoprax.
Used for treating symptoms of colds and flu.
Provides anti-inflammatory, analgesic, and antipyretic effects.
Indicated as analgesic and antipyretic for pain relief.
Used for acute pain and inflammation relief.
Investors in Multilab
Multilab has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Takeda Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Takeda Pharmaceuticals is engaged in developing innovative medicines globally. | 1781 | takeda.com | Tokyo, Japan |
Investor details for Multilab
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Multilab
2 dated milestones of Multilab across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Multilab is founded.
- Exit Acquired by Takeda.
Web traffic of Multilab
The website of Multilab (multilab.com.br) receives about 9.3K visits a month.
- Monthly visits9.3K
▲ 16.5% vs previous month
Websites whose visitors overlap most with Multilab. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| farmagora.com.br | 100% | #6,234,052 | View details | ||
| mevofarma.com.br | 85% | 138K | #337,329 | View details | |
farmaciamix.com.br | farmaciamix.com.br | 82% | #4,980,808 | – | |
drogarianovaesperanca.com.br | drogarianovaesperanca.com.br | 41% | #72,448 | – | |
araujo.com.br | araujo.com.br | 41% | #17,302 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Multilab
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Multilab
Multilab was founded in 1988.
Multilab is headquartered in Porto Alegre, Brazil. It is registered at Porto Alegre, Rio Grande Do Sul, Brazil.
Multilab, a Brazilian company, is involved in the research, development, production, and distribution of pharmaceutical products across various therapeutic areas. It operates within the healthcare sector, offering a wide portfolio of medications, including prescription and over-the-counter drugs. As part of Grupo NC, one of the largest pharmaceutical groups in Latin America, Multilab focuses on providing accessible medicinal solutions through a presence in over 87,000 points of sale. Its offerings address diverse health needs with a commitment to quality and trust.
Multilab offers ResfeGripe, Buprovil, Multipiral, and Nexoprax.
Multilab has 1 investor. Key investors include Takeda Pharmaceuticals.
Multilab operates through Multilab Indústria E Comércio De Produtos Farmacêuticos Ltda.
Yes. Multilab was acquired by Takeda in May 2012.
